Nikhil Khandelwal, Managing Director at Systematix Group, remains positive on State Bank of India and advises long-term investors to stay invested, supported by its diversified businesses and improving profitability.

Mr Vishal Manchanda, in an interaction with CNBC-TV18, shares his perspective on recent regulatory updates and company-specific developments across the sector.

Systematix Group’s Mr Vishal Manchanda, in an interaction with CNBC-TV18, shares his outlook on the sector, highlighting potential margin pressures and company-specific trends.

Mr. Nikhil Khandelwal, in conversation with CNBC TV18, shared insights on the top sectors and Systematix preferred stock picks for 2026.

From patent expiries to emerging generic opportunities, Mr Vishal Manchanda discusses the evolving weight-loss drugs landscape in India on CNBC-TV18.